Login / Signup

One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study.

Rahul S DalalGovind KallumkalHeidy J CabralEdward L BarnesJessica R Allegretti
Published in: The American journal of gastroenterology (2024)
Upadacitinib was more effective at achieving SFCR in UC at 52 weeks vs tofacitinib.
Keyphrases
  • ulcerative colitis
  • rheumatoid arthritis
  • cross sectional
  • gestational age
  • double blind